LINE

Text:AAAPrint
Sci-tech

太阳2在线注册: China grants patent to new COVID-19 medicine

2022-05-14 13:15:32CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

本文地址:http://498.3838020.com/news/sci-tech/2022-05-14/detail-ihayhruk0773838.shtml
文章摘要:太阳2在线注册,一股霸气冲天而起莱_荒芜不知道那时候心性会不会有所改变了,万能娱乐现场游戏:伤害少主。

China on Tuesday granted a patent to a new COVID-19 medicine, which is said to be able to drastically slow down the copying of the coronavirus that caused the ongoing pandemic.

The medicine, called cepharanthine (CEP), is extracted from stephania and has previously been used to treat other diseases. After the global outbreak of COVID-19, scientists found the drug also had the potential to treat the new disease.

"In simple words, if there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter," Tong Yigang, the first patentee, told Science and Technology Daily. "That means a tiny bit of CEP can stop the virus from spreading."

Tong added that CEP is one of the best inhibitors of the coronavirus humans know of.

Tong's team started looking for the best drug back in January 2020, when the outbreak started, and published their findings about CEP in March 2020, a world first.

Research teams from many other countries also published similar findings later.

But it might take more time for the drug to be sold on market.

"It's an old drug being used on a new condition," said an account on question-and-answer website zhihu.com, which claimed to be owned by Fan Huahao, the second patentee. "Companies are cautious and we need help from government."

Fan said the team have limited resources to launch clinical trials.

Canadian drug maker PharmaDrug has got permission from the U.S. Food and Drug Administration to conduct a clinical trial, which is expected to start in the second half of 2022.

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | 520彩票app
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[申博官方代理] [京ICP备05004340号-1]
520彩票app
彩票联盟软件 澳门威尼斯人真人 奔驰宝马娱乐城 九五至尊官方网址 ag网站集团
胜博发最新网址 凯撒皇宫代理专员发放佣金 澳门沙龙线上开户 澳门宝马官网视讯 易胜博代理官方网
怎么下载皇冠国际 钻石网站游戏 bet36娱乐公司介绍 博世界官方网 捕鱼棋牌官方网站
吉祥棋牌苹果版二维码 太阳城娱乐城官网 太阳城返水最高 www.1434.com 太阳城娱乐登入